274 related articles for article (PubMed ID: 26110972)
1. Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma.
McCormick Matthews LH; Noble F; Tod J; Jaynes E; Harris S; Primrose JN; Ottensmeier C; Thomas GJ; Underwood TJ
Br J Cancer; 2015 Jun; 113(1):107-18. PubMed ID: 26110972
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
Smith RA; Tang J; Tudur-Smith C; Neoptolemos JP; Ghaneh P
Br J Cancer; 2011 Apr; 104(9):1440-51. PubMed ID: 21448172
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas.
Creemers A; Ebbing EA; Pelgrim TC; Lagarde SM; van Etten-Jamaludin FS; van Berge Henegouwen MI; Hulshof MCCM; Krishnadath KK; Meijer SL; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
Sci Rep; 2018 Sep; 8(1):13281. PubMed ID: 30185893
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis.
Fisher OM; Lord SJ; Falkenback D; Clemons NJ; Eslick GD; Lord RV
Gut; 2017 Mar; 66(3):399-410. PubMed ID: 26733670
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.
Chen M; Huang J; Zhu Z; Zhang J; Li K
BMC Cancer; 2013 Nov; 13():539. PubMed ID: 24206575
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
[TBL] [Abstract][Full Text] [Related]
7. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma.
Prins MJ; Verhage RJ; ten Kate FJ; van Hillegersberg R
J Gastrointest Surg; 2012 May; 16(5):956-66. PubMed ID: 22258871
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis.
Chen M; Cai E; Huang J; Yu P; Li K
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1126-34. PubMed ID: 22564870
[TBL] [Abstract][Full Text] [Related]
11. Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.
Jamieson NB; Carter CR; McKay CJ; Oien KA
Clin Cancer Res; 2011 May; 17(10):3316-31. PubMed ID: 21444679
[TBL] [Abstract][Full Text] [Related]
12. Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma.
Ong CA; Shapiro J; Nason KS; Davison JM; Liu X; Ross-Innes C; O'Donovan M; Dinjens WN; Biermann K; Shannon N; Worster S; Schulz LK; Luketich JD; Wijnhoven BP; Hardwick RH; Fitzgerald RC
J Clin Oncol; 2013 Apr; 31(12):1576-82. PubMed ID: 23509313
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
[TBL] [Abstract][Full Text] [Related]
14. Loss of SRY-box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma.
Ten Kate FJC; van Olphen SH; Bruno MJ; Wijnhoven BPL; van Lanschot JJB; Looijenga LHJ; Fitzgerald RC; Biermann K
Br J Surg; 2017 Sep; 104(10):1327-1337. PubMed ID: 28692180
[TBL] [Abstract][Full Text] [Related]
15. GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma.
Gotovac JR; Liu DS; Yates MJ; Milne JV; Macpherson AA; Simpson KJ; Eslick GD; Mitchell C; Duong CP; Phillips WA; Clemons NJ
J Pathol; 2020 Nov; 252(3):317-329. PubMed ID: 32737994
[TBL] [Abstract][Full Text] [Related]
16. Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis.
Ruys AT; Groot Koerkamp B; Wiggers JK; Klümpen HJ; ten Kate FJ; van Gulik TM
Ann Surg Oncol; 2014 Feb; 21(2):487-500. PubMed ID: 24081803
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer.
Yagi T; Baba Y; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Watanabe M; Baba H
Ann Surg; 2019 Mar; 269(3):471-478. PubMed ID: 29206673
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol.
Nieto T; Tomlinson CL; Dretzke J; Bayliss S; Dilworth M; Beggs AD; Tucker O
BMJ Open; 2016 Dec; 6(12):e013361. PubMed ID: 27927666
[TBL] [Abstract][Full Text] [Related]
19. Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.
Bain GH; Collie-Duguid E; Murray GI; Gilbert FJ; Denison A; McKiddie F; Ahearn T; Fleming I; Leeds J; Phull P; Park K; Nanthakumaran S; Matula KM; Grabsch HI; Tan P; Welch A; Schweiger L; Dahle-Smith A; Urquhart G; Finegan M; Petty RD
Br J Cancer; 2014 Mar; 110(6):1525-34. PubMed ID: 24569475
[TBL] [Abstract][Full Text] [Related]
20. Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma.
Noble F; Mellows T; McCormick Matthews LH; Bateman AC; Harris S; Underwood TJ; Byrne JP; Bailey IS; Sharland DM; Kelly JJ; Primrose JN; Sahota SS; Bateman AR; Thomas GJ; Ottensmeier CH
Cancer Immunol Immunother; 2016 Jun; 65(6):651-62. PubMed ID: 27020682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]